Application of tumor measurement-based metrics in the real world

Journal of Clinical Oncology

Volumn 31, Issue 34, 2013, Pages 4374-

  An, Ming Wen ^a   Mandrekar, Sumithra J ^b   Sargent, Daniel J ^b  

^a VASSAR COLLEGE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER SURVIVAL; FOLLOW UP; HUMAN; LETTER; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MEASUREMENT; TUMOR VOLUME; COLORECTAL TUMOR; FEMALE; MALE; NOTE; PATHOLOGY; COLORECTAL NEOPLASMS;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE;

EID: 84892877732     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.52.3662     Document Type: Letter

References (3)

1. Claret L, Gupta M, Han K, et al: Evaluation of tumor-size response metrics to predict overall survival in Western and Chinese patients with first-line metastatic colorectal cancer. J Clin Oncol 31:2110-2114, 2013
2. Hillman SL, An MW, O'Connell MJ, et al: Evaluation of the optimal number of lesions needed for tumor evaluation using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group investigation. J Clin Oncol 27:3205-3210, 2009
3. Broglio KR, Berry DA: Detecting an overall survival benefit that is derived from progression-free survival. J Natl Cancer Inst 101:1642-1649, 2009